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Hearing loss is one of the most prevalent conditions around the world, in particular
among people over 60 years old. Thus, an increase of this affection is predicted
as result of the aging process in our population. In this context, it is important to
further explore the function of molecular targets involved in the biology of inner ear
sensory cells to better individuate new candidates for therapeutic application. One of
the main causes of deafness resides into the premature death of hair cells and auditory
neurons. In this regard, neurotrophins and growth factors such as insulin like growth
factor are known to be beneficial by favoring the survival of these cells. An elevated
number of published data in the last 20 years have individuated sphingolipids not only
as structural components of biological membranes but also as critical regulators of
key biological processes, including cell survival. Ceramide, formed by catabolism of
sphingomyelin (SM) and other complex sphingolipids, is a strong inducer of apoptotic
pathway, whereas sphingosine 1-phosphate (S1P), generated by cleavage of ceramide
to sphingosine and phosphorylation catalyzed by two distinct sphingosine kinase (SK)
enzymes, stimulates cell survival. Interestingly S1P, by acting as intracellular mediator
or as ligand of a family of five distinct S1P receptors (S1P1–S1P5), is a very powerful
bioactive sphingolipid, capable of triggering also other diverse cellular responses such as
cell migration, proliferation and differentiation, and is critically involved in the development
and homeostasis of several organs and tissues. Although new interesting data have
become available, the information on S1P pathway and other sphingolipids in the biology
of the inner ear is limited. Nonetheless, there are several lines of evidence implicating
these signaling molecules during neurogenesis in other cell populations. In this review,
we discuss the role of S1P during inner ear development, also as guidance for future
studies.
Keywords: sphingosine 1-phosphate, sensory hair-cells, inner ear neurogenesis, hearing loss, auditory neurons,
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Sphingosine 1-Phosphate as Sphingolipid Metabolite
Sphingolipids are a fascinating subclass of complex lipids known since a long time as key
players in the correct structural organization of biological membranes. Subsequently to the
understanding of their fundamental structural properties, it has been made clear that intermediates
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in their biosynthesis and breakdown are indeed critical signaling
molecules implicated in the regulation of essential biological
events. In this regard, it is presently well accepted that the vast
majority of the extracellular cues involved in the regulation of cell
functioning exploits at least in part sphingolipid metabolism for
the accomplishment of a variety of specific biological responses.
Among the various types of sphingolipids, sphingomyelin
(SM) is of paramount relevance as potential source of bioactive
sphingoid molecules. Numerous reviews focus on the intricate
regulation of the sphingolipid pathway (Huwiler et al., 2000;
Hannun and Obeid, 2008; Figure 1). Its breakdown, catalyzed
by a small family of SMases, gives rise to the formation of
ceramide, an intracellular mediator per se, as well as a central
hub for the production of other critical bioactive compounds.
Ceramide is composed by a sphingoid base, named sphingosine,
linked to a fatty acid via an amide bond, thus, depending on
the length of the fatty acid acyl chain, various types of ceramide
do exist. Another metabolic pathway that can produce ceramide
is represented by its de novo synthesis that begins with the
condensation of palmitoyl-CoA and serine catalyzed by serine
palmitoyl transferase to give 3-keto-dihydrosphingosine, then
reduced to dihydrosphingosine, followed by acylation reaction
performed by a family of six distinct ceramide synthases,
several of which are co-expressed in many different cell
systems (Stiban et al., 2010; Mullen et al., 2012). The last
step involves the oxidation of dihydroceramide to ceramide
which is dependent on the action of a specific desaturase.
Accumulation of ceramide within the cell is associated with
a number of biological responses including cell growth
arrest, apoptotic cell death, cell senescence, stress response
making the regulation of its intracellular content critical for
the fate of a given cell type (Hannun and Obeid, 2011).
Once produced, ceramide can be utilized in various distinct
biosynthetic pathways. The most abundant sphingolipid in
plasma membrane, named SM, is generated by SM synthases
in a reaction that, via transfer of phosphocholine from
phosphatidylcholine onto ceramide, yields also diacylglycerol
(Taniguchi andOkazaki, 2014). Alternatively, ceramide can serve
as backbone in the building of glycosphingolipids, the first
step being catalyzed by glucosylceramide synthase (GCS), which
produces glucosylceramide, the simplest member of this family
(Messner and Cabot, 2010). In turn, by addition of a galactose
moiety glucosylceramide is transformed into lactosylceramide,
which, by addition of one or more monosaccharides, gives raise
to individual ganglioside species, recognized as vital components
of membrane microdomains with a role in cell-cell recognition,
adhesion, and signal transduction (D’Angelo et al., 2013).
Moreover, selective phosphorylation of ceramide brought about
by ceramide kinase (CK) generates ceramide 1-phosphate, a
bioactive sphingolipid regarded as a powerful pro-inflammatory
mediator (Gomez-Muñoz et al., 2013).
Finally, it is worth noticing that also the catabolic route by
which ceramide is degraded is responsible for the production
of other bioactive sphingoid compounds, among which
sphingosine 1-phosphate (S1P) plays a prominent role. S1P is
produced by ceramide via two specific enzymatic reactions:
at first ceramidases (CDase) catalyze ceramide deacylation
to sphingosine (Mao and Obeid, 2008; Ito et al., 2014), then
the sphingoid base is phosphorylated to S1P by sphingosine
kinase (SK). Two distinct isoforms of SK exist, designated
SK1 and SK2 (Takabe et al., 2008). They are ubiquitously
expressed, each contributing to intracellular S1P production.
Although in some instances SK1 and SK2 can have overlapping
functions, in certain cell types they have been found to differ
for intracellular localization, as well as for their biological
role (Maceyka et al., 2012; Neubauer and Pitson, 2013).
Catabolism of S1P is also under the control of multiple
enzymes. S1P lyase catalyzes the irreversible breakdown of
S1P to hexadecenal and phosphoethanolamine (Kumar and
Saba, 2009), while two distinct specific S1P phosphatases by
removing the phosphate moiety generate sphingosine, that can
be further phosphorylated to S1P or employed to feed into the
so called sphingolipid salvage pathway, responsible for ceramide
biosynthesis from sphingolipid breakdown (Le Stunff et al.,
2002).
S1P was discovered as an intracellular mediator more than
20 years ago, even though some of its intracellular targets have
been identified only recently (Maceyka et al., 2012). Meanwhile,
a large body of experimental evidence has been accumulated in
favor of the critical role played by S1P as ligand of a family of
five specific, high affinity, G protein coupled receptors named
S1P1–5 (Ishii et al., 2004; Meyer zu Heringdorf and Jakobs, 2007).
The majority of these receptors are able to activate multiple
heterotrimeric G proteins, making thus possible the triggering
of a wide variety of signaling pathways as well as various
biological responses. Notably, S1P1, S1P2 and S1P3 are almost
ubiquitous, while S1P4 and S1P5 expression appears to be limited
to specific cell types such as those belonging to lymphoid and
nervous tissue (Im et al., 2000; Kluk and Hla, 2002). Thus,
taking into consideration the selective signaling downstream of
individual S1P receptor subtypes, the final biological response
evoked by S1P in a given cellular setting is specific, being
often strictly dependent on the specific pattern of S1P receptor
expressed. Exogenous S1P, mainly via ligation to one or more
S1P receptors, is capable of regulating key biological processes,
including cell proliferation, survival, motility as well as cell
differentiation (Mendelson et al., 2014). Since ceramide and S1P
are readily interconvertible lipids exerting opposite biological
actions, the balance of their intracellular content is regarded as
a biostat determining cell fate (Maceyka et al., 2002). Circulating
plasma contains high nanomolar levels of S1P, whereas S1P
availability within tissues is much lower (Schwab et al., 2005).
The occurrence of such a gradient between blood and tissues
is of utmost importance for the correct driving of lymphocyte
and hematopoietic cell trafficking (Cyster and Schwab, 2012).
Specific cell types such as erythrocytes, platelets and endothelial
cells are responsible for the maintaining of the relatively high
concentration of S1P in plasma (Pappu et al., 2007), although
in principle every cell system can release endogenous S1P
in the extracellular environment via the functioning of the
widely expressed selective S1P transporter spinster-2 (SPNS2;
Kawahara et al., 2009), as well as other less specific transporters
such as several members of the ATP binding cassette (ABC)
family (Nishi et al., 2014). Indeed, release of S1P by a given
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FIGURE 1 | Metabolism of sphingolipids. Ceramide is considered the hearth
of sphingolipid metabolism. It can be formed by de novo synthesis and then
converted to other bioactive lipids. Sphingosine 1-phosphate lyase (S1P lyase)
catalyzes the irreversible exit from the pathway. Abbreviations: serine
palmitoyl-CoA-acyltransferase (SPT), 3-ketosphinganine reductase (KSR),
(dihydro)-ceramide synthase (CerS), ceramide desaturase (DES), ceramide
kinase (CK), glucosylceramide synthase (GCS), glucosyl ceramidase (GCase),
ceramidase (CDase), sphingosine-1-phosphate lyase (S1P lyase), sphingosine
kinase (SK), sphingosine 1-phosphate phosphatase (S1PPase), sphingomyelin
(SM) synthase (SMS), sphingomyelinase (SMase).
cell is regarded as a crucial step in the general mechanism
by which this sphingolipid can act as paracrine or autocrine
cue in the so called inside-out signaling (Figure 2). In this
regard it has been clearly established that in a wide variety of
cellular contexts intracellular S1P metabolism is tightly regulated
by multiple extracellular agents including growth factors,
hormones, cytokines and neurotransmitters and the subsequent
functional interaction with S1P receptors is integral to their
final biological actions (Takabe et al., 2008; Xia and Wadham,
2011; Maceyka et al., 2012). Interestingly, extensive experimental
evidence has been provided for the occurrence of a complex
cross-talk between S1P signaling axis and numerous different
extracellular agents including: epithelial growth factor (EGF),
platelet derived growth factor (PDGF), vascular endothelial
growth factor (VEGF), IGF1, as well as tumor necrosis factor
alpha (TNFα) and transforming growth factor beta (TGFβ), that
comprises expression changes of S1P receptors and/or enzymes
of S1P metabolism and/or S1P-dependent transactivation of
enzyme-linked membrane receptors (Pyne et al., 2003; Takabe
et al., 2008; Xia and Wadham, 2011; Maceyka et al., 2012; Donati
et al., 2013a,b).
S1P Signaling Axis in Nervous Tissue
In keeping with the essential role of S1P metabolism and
signaling for correct vertebrate development, S1P biosynthesis
was found to be necessary for embryonal neurogenesis.
Double knockout (KO) mice for SK1 and SK2 exhibited
a severely disturbed neurogenesis, including neural tube
closure, defects in angiogenesis and caused embryonic lethality
(Mizugishi et al., 2005). The observed neural tube defect
was ascribed to the absence of S1P and the consequent
increased apoptosis of neuroepithelium. The biological action
of S1P was mediated at least in part by S1P1, given that
S1pr1 KO mice were found to display similar, even though
milder, neural defects (Liu et al., 2000). A number of
different studies have implicated S1P in the control of multiple
biological events that occur in the various cell types present
in central nervous tissue. Neural progenitor cells express
S1P receptors and proliferate in response to S1P challenge
(Harada et al., 2004); moreover, they are recruited by this
bioactive sphingoid molecule toward a pathological area of the
central nervous system (CNS) in a S1P1-dependent manner
(Kimura et al., 2007). In this regard, S1P-mediated migration
of neural progenitor cells toward an area of brain injury was
found to be enhanced by antagonizing S1P2 (Kimura et al.,
2008).
S1P is also efficacious in regulating proliferation of astrocytes
(Sorensen et al., 2003; Bassi et al., 2006), specialized glial cells that
by interacting with blood vessels and synapses regulate multiple
aspects of brain homeostasis and functioning. Importantly, S1P
was found to be secreted in response to fibroblast growth
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FIGURE 2 | Schematic diagram describing the inside-out signaling of
S1P. Sphingosine kinase (SK) activation by different extracellular agents leads
to S1P production that both can act via intracellular targets or is extracellularly
released to bind specific S1P receptors (S1P1–5). Transporters have been
involved in S1P export such as the ATP binding cassette (ABC), and the specific
spinster 2 (SPNS2).
factor 2 (FGF2) identifying an autocrine/paracrine mechanism
of action of this sphingolipid in the proliferation of astrocytes,
with a role in the FGF2-induced cell growth signaling (Bassi
et al., 2006). Since a pilot study reported that S1P induces
the expression of Fgf2 mRNA in rat astrocytes (Sato et al.,
2000), it is tempting to speculate that a positive feedback
loop takes place between FGF2 and S1P signaling pathway in
astrocytes.
The finding that S1P5 is abundantly expressed in the white
matter of brain (Im et al., 2001) led to the identification of this
receptor subtype as predominantly present in oligodendrocytes,
the myelinating cells of the CNS. In pre-oligodendrocytes S1P
acting via S1P5 elicited process retraction, whereas it promoted
survival of mature cells (Jaillard et al., 2005). However, S1P5
is not the unique transducer of S1P action in this cell type
since S1P1 was reported to be up regulated by PDGF in
oligodendrocyte progenitors and implicated in the growth factor-
induced mitogenesis (Jung et al., 2007).
A wealth of experimental data mainly performed in
hippocampal neurons support an important role of S1P receptors
in the modulation of neuronal excitability as well as synapse
plasticity and transmission (Kajimoto et al., 2007; Sim-Selley
et al., 2009; Kanno et al., 2010; Norman et al., 2010; Kempf
et al., 2014). In agreement, aberrant S1P levels and S1P
receptor signaling have been reported in a range of diseases
of CNS. In multiple sclerosis patients S1P concentration in
cerebrospinal fluid was augmented, in accordance with the
chronic inflammation status associated with this degenerative
disease (Kulakowska et al., 2010). S1P concentrations were
selectively decreased in the cerebrospinal fluid of adult rats in
an acute and an inflammatory pain model (Coste et al., 2008).
Finally, region specific S1P content decline was recently observed
during the course of Alzheimer’s disease, primarily attributed
to a loss of SK1 and SK2 in the hippocampus (Couttas et al.,
2014).
It is important to underline that the recently developed
fingolimod (FTY720) as oral therapy of multiple sclerosis directly
targets S1P signaling pathway (Brinkmann et al., 2010). This
compound is converted in vivo by SK2 into p-FTY720, that acts
as high affinity agonist for all S1P receptors, except S1P2, and
results in sequestration of lymphocytes into secondary lymphoid
tissues. Besides this keymechanism of action, nonimmunological
CNS mechanisms for fingolimod efficacy in multiple sclerosis
therapy were identified that implicate S1P1 signaling in astrocytes
as a key mediator, thus highlighting S1P signaling pathways
within the CNS as targets for multiple sclerosis therapies (Choi
et al., 2011). Intense recent studies aimed at exploring additional
therapeutic applications of fingolimod, reviewed exhaustively
in Brunkhorst et al. (2014), have produced very promising
results that hopefully will enable the translation of some of
these experimental findings into the clinics opening new avenues
for the treatment of Alzheimer’s disease, cerebral malaria,
neuroblastoma and neuroprotection in cranial irradiation,
among others.
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An Overview of Inner Ear Morphogenesis
The mature inner ear of mammals is a remarkable structure
composed by a myriad of exquisitely arranged cell types within
a complex set of ducts and chambers: the vestibular system
composed of the semicircular canals, the saccule and the
utricle, and the auditory system formed by the cochlea, a
convoluted structure where the organ of Corti (OC) resides.
In this review we will emphasize the auditory system, in
particular the spiral ganglion neurons (SGN), the innervation
that transports the electrical stimulus from OC to the CNS.
Although many questions are still open, the molecular events
occurring from the initial formation of the otic placode, to
the final complex tonotopic arrangement of mature SGN are
starting to be understood. Several signaling pathways govern
every stage in inner ear development, for example members
of the FGF and WNT families are between the earliest
signals triggering otic development. Later on, retinoic acid
(RA) and IGF1 play an important role in the regionalization
of the otic vesicle and the survival of auditory neuroblasts.
Perhaps some of the most studied proteins involved in the
development of SGN are neurotrophins, in particular brain-
derived neurotrophic factor (BDNF) and neurotrophin 3 (NT3).
The study of these neurotrophins and other signaling molecules
involved in the formation and survival of SGN is also
relevant from the point of view of therapeutic applications,
since SGN are critical in the effectiveness of the cochlear
implant.
In addition, in recent years several stem cell-based
differentiation protocols have been proposed to create hair
cells and sensory neurons that could be used in cell-replacement
strategies (Oshima et al., 2010; Koehler and Hashino, 2014).
Indeed it was recently shown that human embryonic stem
cell-derived inner ear progenitors are able to restore hearing
in deafened gerbils (Chen et al., 2012). It is worth mentioning
that this and other protocols are developmentally-informed
approaches, highlighting that a better understanding of inner ear
development will be translated in more efficient differentiation
protocols.
As previously mentioned, S1P signaling is functionally
ubiquitous, and our group and others have shown that several
cytokines, growth factors and morphogenetic cues modulate and
are modulated by S1P receptors, S1P lyase and SKs.
We will briefly revisit the development of the inner and the
main morphogenetic cues involved in the process and present
the current knowledge on the interaction of such cues with S1P
pathway in other systems. The evidence presented suggest that
apart from the essential role of S1P signaling in hearing, it is
worth looking at S1P pathway at earlier developmental stages.
The Pre-Placodal Region and the
Formation of the Otic Placode
Preceding the formation of the otic placode, the border region
between the neural plate and the lateral ectoderm acquires the
competence to respond to otic inducing signals. This region
surrounding the head ectoderm called the pre-placodal domain
(PPD) is established by the cooperation of bone morphogenetic
protein (BMP), WNT and FGF signals emanating from the
mesenchyme and the neural plate.
In X.laevis, the PPD marker Six1 is expressed in animal caps
when the BMP inhibitors noggin and cerberus are overexpressed
(Brugmann et al., 2004). In line with this, BMP blocks the
expression of Six1 in its endogenous domain while noggin
expands it (Ahrens and Schlosser, 2005).
In the chick Wnt8a and BMPs are expressed posteriorly and
laterally to the PPD and when these pathways are blocked, the
expression of the PPD markers SIX4 and EYA2 expands beyond
its endogenous territory (Litsiou et al., 2005). In both works it
was also demonstrated that FGF signaling was necessary to fully
induce the expression of the PPD markers ectopically (Ahrens
and Schlosser, 2005; Litsiou et al., 2005).
The PPD is the common ground of all cranial placodes,
characterized by the expression of members of DLX and FOX
families of transcription factors in several species (Quint et al.,
2000; McLarren et al., 2003; Hans et al., 2004). Experiments in
the chick have shown that FGF2 is able to induce the early otic
marker PAX2 in explants derived from any region within the
PPD but not in lateral or trunk ectoderm (Martin and Groves,
2006). Similarly in the Zebrafish fgf8 misexpression can enlarge
the size of the otic vesicle only in the regions where PPDmarkers
have been previously expressed (Hans et al., 2004).
FGF family are also important signals that initiate inner
ear development across vertebrates. In particular, the role of
FGF3 during otic induction is conserved in different species.
However, other FGFs such as FGF8, FGF10, FGF19 are also
involved depending on the species. For example, zebrafish
embryos treated with the FGF receptor inhibitor SU5402,
or fgf3/fgf8 morpholino injected do not form otic vesicles
neither express the placodal marker Pax8 (Phillips et al., 2001;
Maroon et al., 2002). In the chick FGF19 and FGF3 have a
synergistic effect during otic placode induction (Ladher et al.,
2000), although FGF2 has also been shown to induce the
expression of the otic markers PAX2 and DlX3 (Martin and
Groves, 2006). In mice, FGF3 together with FGF10 play a
redundant role during otocyst formation, double KO animals
are completely devoid of otocyst (Alvarez et al., 2003; Wright
and Mansour, 2003; Zelarayan et al., 2007). In line with this,
FGF receptor 2 isoform IIIb (Fgfr2IIIb) KO mice, the receptor
isoform for FGF3 and FGF10, present gross morphological
defects in the inner ear (Xu et al., 1998; Pirvola et al.,
2000).
In addition to the FGF signals, WNT plays also important
role during the induction and formation of the otic placode.
For example, it has been reported that WNT8A induces the
expression of FGF3 before the appearance of otic placode
markers in the chick (Ladher et al., 2000). In murine models,
conditional expression and deletion of β-catenin (CTNNB1)
within the PAX2 territory increases or diminishes respectively
the size of the otic domain (Ohyama et al., 2006). In agreement,
overexpression ofDkk1 gene, aWNT signaling inhibitor, impairs
the development of the otic placode (Freter et al., 2008).
In summary, FGFs together with a specific level of BMP and
WNT signaling inhibition first establish the PPD. Then local
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FGFs (e.g., FGF3 and FGF10) restrict the formation of the otic
placode next to the hindbrain, which is then compartmentalized
into otic and epidermis fates by the action of WNT signals.
To our knowledge, only one study has evaluated the direct
involvement of S1P signaling during inner ear development
(Hu et al., 2013), however there are reports indicating that S1P
axis is involved in the signaling pathways that are required
for the proper development of the inner ear. For example,
in PC12 cells nerve growth factor (NGF) and FGF2, both
important differentiation signals acting via tyrosine kinase
receptors, increase the extracellular levels of S1P (Rius et al.,
1997), suggesting that even different signaling molecules share
in common the modulation of the S1P metabolism. Likewise,
in astrocytes FGF2 can increase the activity of SK and the
secretion of S1P, while S1P also induces the expression of
FGF2 and phosphorylate ERK (Sato et al., 1999; Bassi et al.,
2006), supporting the existence of a positive feedback regulatory
loop between both signaling pathways in these cells. Analogous
interaction of S1P and FGF signaling has been observed in
human umbilical vein endothelial cells (HUVECs), where S1P
induces the expression of VEGF, an important angiogenic
factor. In these cells it was observed that the S1P-induced
expression of FGF1 and its specific receptor FGFR1 preceded
that of VEGF, since in cells treated with the FGFR inhibitor
SU5402 or transfected with FGF1 and FGFR1 siRNA, S1P
was unable to induce the VEGF expression (Chang et al.,
2013). As observed in astrocytes, in HUVECs a mutual
regulation between FGF and S1P signaling pathways occurs.
For instance, it has been recently shown that FGF signaling
is capable of regulating S1P metabolism by inducing the
expression of SK1. In this system, the transcription factor
KLF14, induced by FGF2, directly binds to the promoter region
of SK1 gene (de Assuncao et al., 2014), establishing more
clearly the mechanism of interaction between FGF and the
S1P axis.
S1P plays also an important role in osteoblast differentiation.
Osteoclast-conditioned medium induced the differentiation of
human mesenchymal stem cells (hMSCs) towards osteoblasts.
SK1, BMP6, WNT10B genes were highly expressed by osteoclasts
and indeed when S1P signaling was blocked in hMSCs,
differentiation and chemokinesis were reduced (Pederson et al.,
2008). In addition, in osteoblasts it has been recently found
that S1P axis increases BMP2-induced differentiation through
the phosphorylation of ERK and Smad1/5/8 at a level higher
than that observed following BMP2 treatment alone (Sato
et al., 2012). Thus in this system S1P works as enhancer
of the biological effect exerted by BMP signaling. Also in
osteoblasts, S1P has been shown to interact with WNT signaling
pathway by activating AKT, which inhibits GSK3β and lead
to the nuclear traslocation of β-Catenin, downstream effector
of WNT signaling. Indeed WNT3a-induced differentiation
was impaired by the use AKT pharmacological inhibitors
(Matsuzaki et al., 2013). These results and the known effects
of BMP and WNT signaling in differentiation suggest that
S1P could also behave as an enhancer of WNT signaling
in bone formation similarly to its interaction with the BMP
pathway.
Regionalization of the Otic Vesicle and the
Development of Sensory Neurons
Although morphologically uniform, the otocyst is
compartmentalized by the expression of otic markers allocated
at different regions within the otocyst. Members of Notch, FGF,
RA and SHH signaling pathways are involved in this process.
Although Fgf3/Fgf10 double KO mice lack completely otic
vesicle, the effect of single mutation affects only the expression
patter of individual markers, such as DLX5 and PAX2, within the
vesicle (Wright and Mansour, 2003). Indeed FGF3 and FGF10
are also expressed at different territories in the otocyst (Pirvola
et al., 2000), suggesting that FGFs are important in otocyst
regionalization.
RA is a morphogen with a known role in otic vesicle
regionalization. In chick and mouse it was found that RA
synthesis and degradation are allocated to the posterior and
anterior ectoderm respectively, creating in this manner a RA
gradient in the otic vesicle. Indeed exposure to RA posteriorise
the entire otocyst, reducing the size of the prosensory domain,
the area where sensory cells arise (Blentic et al., 2003; Bok et al.,
2011). In the zebrafish RA expands anteriorly the expression
of the transcription factor Tbx1 normally restricted to the
posterior otic vesicle. This leads to increased Notch activation
and reduction of the sensory domain (Radosevic et al., 2011).
RA also controls the expression pattern of FGF3 and FGF10,
which may underlie the development of the sensory domain
(Cadot et al., 2012; Economou et al., 2013). In this regard, it has
been shown that FGF10 expression precedes the proneural genes
Neurog1 and Neurod1 in the otocyst, and FGF10 overexpression
increases the number of neuroblasts that delaminate (Alsina
et al., 2004).
Sonic hedgehog (SHH) is another signaling molecule that
participates in the formation of the otocyst ventromedial domain.
Shh KO mice fail to maintain the expression of PAX2, OTX2,
in the otocyst neurogenic region. As a consequence, ventral
structures such as the cochlea and the cochlear ganglion never
form (Riccomagno et al., 2002; Bok et al., 2007).
As early as E9 in the mouse, sensory neuroblast start to
delaminate from the ventral neurogenic domain of the otocyst,
the process continues until E14. Notch, neurotrophins and
IGF1 are important in the differentiation and survival of
neuroblast. Notch pathway has several functions, it restricts the
non-neuronal domain of the otic vesicle posteriorly, and in
the other hand, by mechanism of lateral inhibition limits the
number of otic neuroblast that delaminate (NEUROD1+ cells)
(Haddon et al., 1998; Abelló et al., 2007). In general, it has
been observed that Notch signaling activation is necessary to the
formation of sensory cells (Kiernan et al., 2006; Daudet et al.,
2007). Indeed, the cell decision between neurogenic vs. sensory
is regulated by Notch as NEUROG1+ cells restrict neighbor
cells of adopting a neural fate but maintains them as sensory
precursors (Raft et al., 2007). As neuroblasts (NEUROG1+)
continue their way out of the otocyst, another transcription
factor NEUROD1 is switched on. These genes are considered
to be essential in the formation of the spiral ganglion. Neurog1
and Neurod1 KO mice lack completely innervation to the
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cochlea which appears morphologically normal (Ma et al., 2000;
Kim et al., 2001). However, Neurod1 mutants form sensory
neurons but these do not mature and undergo apoptosis.
The expression of the neurotrophin receptors TRKB and
TRKC failed in these animals, explaining the increased cell
death.
Neurotrophins are important survival factors for many
neuronal populations. The inner ear expresses two of them,
BDNF and NT3 which are essential for the development of the
SGNs. Double KO mice for either Bdnf/Nt3 or their receptors
TrckB/TrckC are devoid of cochlear innervation (Ernfors et al.,
1995; Silos-Santiago et al., 1997). Their expression pattern forms
a gradient for the topographic organization of the sensory
neurons (Pirvola et al., 1992; Fariñas et al., 2001). For example
BDNF expression starts at the apex of the cochlea at E12.5
and progresses towards the base as the hair cells mature while
NT3 has an inverse base-to-apex expression pattern (Schimmang
et al., 2003; Sugawara et al., 2007). In fact, exposure to one or
the other changes the behavior of SGN towards apical or basal
neurons regardless of their position (Adamson et al., 2002). It
has been observed that BDNF and NT3 are able to differentially
regulate important electrophysiological proteins such as AMPA
receptors and synaptophisin (Flores-Otero et al., 2007).
There are other cues involved in the formation of the spiral
ganglion. FGFs have been shown to influence the migration
and neurite outgrowth of inner ear neuroblasts. In chick
otocyst explants, the expression of the BDNF receptor, TRKB is
induced by the treatment with FGF2, together with this change,
neural progenitor migration and the axon outgrowth accelerates
(Brumwell et al., 2000).
IGF1 also plays a role in the formation of mature spiral
ganglion cells. Igf1 KO mice are profoundly deaf by the third
postnatal week. Although the cochlea seems normal at birth in
these mice, the maturation of several structures of the inner
ear such as the tectorial membrane and the spiral ganglion is
impaired during the second and third postnatal week (Camarero
et al., 2001). A marked apoptosis of SGNs, decreased soma size
and an immature synapsis with the OC were observed in Igf1
KO mouse. Thus IGF1 is prescindible for normal development
but it is later required for the maturation and survival of spiral
ganglion cells at postnatal stages. Nonetheless examination of
the inner ear of Igf1 KO at earlier developmental stages is still
missing. In chick, IGF1 is necessary for the proliferation and
further differentiation of auditory neuroblasts (Camarero et al.,
2003). The biological effect of IGF1 in this model has been shown
to be mediated by the activation of PI3K-AKT signaling pathway
(Aburto et al., 2012).
Compelling evidence in several cellular settings models
highlights the involvement of S1P axis in the signaling
pathways discussed before. In human breast cancer cell
lines for example, RA has shown an anti-proliferative effect
mediated upon binding to the RA receptor RARα, leading
to overproduction of ceramide and downregualtion of SK1.
On the contrary, in cells transfected with a dominant-negative
form of RARα, RA-induced growth inhibition is hampered,
being accompanied by the increased expression and activity
of SK1 (Somenzi et al., 2007). On the other hand S1P
metabolism affects RA signaling: for example in colon cancer
cells, S1P down-regulates the receptor RARβ, thus making
cells refractory to RA-induced growth inhibition (Sun et al.,
2012).
The cross-talk between neurotrophins and S1P metabolism
is also well established. In PC12 and dorsal root ganglion
cells, neuritogenesis induced by NGF depends in the membrane
translocation of SK1 and the activation of S1P1, while S1P2
and S1P5 have an inhibitory role in neurite formation (Toman
et al., 2004). This underlines the importance of understanding the
function of this pathway in a particular cell type, since different
S1P receptors can trigger disparate biological functions.
In a mouse model of Rett syndrome, Mecp2 KO, the
S1P agonist p-FTY720 showed effectiveness in improving the
symptoms of the disease, correlated with increased BDNF levels
in several neuronal populations (Deogracias et al., 2012). In
another study using cortical neurons p-FTY720 also induced
the expression BDNF which protected cells against oligomeric
amyloid-β toxicity in an in vitro model of Alzheimer disease
(Doi et al., 2013). In oligodendrocytes, NT3-induced survival was
found to be dependent upon SK expression and translocation
(Saini et al., 2005).
Apart from differentiation and survival, it was demonstrated
that NGF increased the number action potentials in sensory
neurons through a SK1-dependent mechanism (Zhang et al.,
2006), even S1P treatment alone was enough augment the
number of action potentials in these cells. Thus, it seems
that the modulation of S1P metabolism is common molecular
mechanism to transmit several of the biological effects elicited
by neurotrophins in diverse neuronal populations.
As regards the interaction of S1P with IGF1 signaling, it
is important to recall that our laboratory recently found an
involvement of S1P axis in IGF1 signaling. We proved that the
myogenic effect of IGF1 in skeletal muscle cells is dependent
on the activity of SK1 and SK2; if these kinases are blocked
by pharmacological inhibitors or siRNA down-regulation, the
expression of the myogenic markers myogenin and caveolin-3
is reduced (Bernacchioni et al., 2012). In the ear, IGF1 is
currently being studied as a potential polypeptide to be used
in the treatment of sensorineural hearing loss and the first
results of a clinical trial involving 25 patients with sudden
sensorineural hearing loss are very promising (Nakagawa et al.,
2014; Yamamoto et al., 2014). Thus, from the point of view of
medical application, it would be very interesting to investigate
the potential involvement of S1P axis in IGF1 signaling in
the context of the inner ear, and explore the possibility of
using S1P or S1P receptor agonists/antagonists to prevent
hearing loss.
In summary, the formation of the inner ear is a complex and
dynamic process that involves the integration of signals such
as WNTs, FGFs, RA, SHH and Notch ligands. The recognized
interaction between these extracellular cues and S1P in other cell
systems should prompt to study its possible involvement in the
inner ear. This would shed light not only in the understanding
of basic development of the inner ear, but also in the translation
of more robust differentiation protocols to generate sensory cells
in vitro from stem/progenitor cells.
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The Role of Sphingolipid Signaling in the
Inner Ear
It is still not clear the precise role of different sphingolipids in
the biology of the inner ear, but there are several reports that
highlight their importance and make them attractive targets that
deserve further investigation.
For example it was recently found that the simplest
ganglioside named GM3, generated by addition of a sialic acid
to lactosylceramide in a reaction catalyzed by GM3 synthase,
plays an important role in inner ear physiology. GM3 synthase
(St3gal5) KO mice have been shown to be profoundly deaf due
to specific deterioration of the OC (Yoshikawa et al., 2009).
The hearing loss started as early as P14, progressing rapidly
and by P17 KO mice were profoundly deaf with a substantial
loss of hair cells. The molecular mechanism responsible for
hearing loss was not determined. Although gangliosides GM3
and GT1b were expressed in the OC, SGN and stria vascularis
(SV), no changes in K+ and endocochlear potential (EP)
were observed in the KO mice (Yoshikawa et al., 2009).
Noteworthy, in rat organotipic cultures gangliosides GM1 and
GM3 were shown to diminish gentamicin-induced hair cell
death (Nishimura et al., 2010). In addition, in the St3gal5
mutants there was an accumulation of other ganglioside species,
whether these can induce apoptosis is unknown. In this regard,
GM3 synthase deficient human fibroblasts showed increased
apoptosis and accumulation of these ganglioside species (Liu
et al., 2008). An alternative explanation could be that GM3-
derived gangliosides could modulate growth factor response
necessary for the maturation and survival. Indeed, in the work of
Liu et al. fibroblasts of such patients have reduced EGF-induced
proliferation and migration (Liu et al., 2008). It is important
to mention that one of these patients was deaf (Fragaki et al.,
2013).
Sphingomyelin, the most abundant sphingolipid in biological
membranes, has also been demonstrated to be involved in
hearing and maintenance of inner ear structures such as SV
and hair cells and the EP. The SM synthase-1 (Sms-1) KO
mouse presents hearing loss although this is milder than the
one observed in St3gal5 KO mouse and other mutant mouse
strains discussed later, Spns2 and Sp1r2 KOs, and affects mainly
the low and middle frequency hearing (Lu et al., 2012). These
mice have a decreased EP compared with wild type (WT) of
the same age, but the drop was not as robust as the ones
observed in the St3gal5KO for example, perhaps accounting
for the milder phenotype. Together with the SV defects and
the decreased EP, there was an aberrant expression of the
K+ channel KCNQ1 in KO mice. However this was probably
a secondary consequence, as its expression in the SV was
only assessed at 3 months of age and the K+ concentration
was found to be equal at 1 month between KO and WT
littermates.
Finally, only recently S1P signaling emerged as an important
pathway in the development of the inner ear and there are
only few reports describing its role. For instance, explants
cultures of rat cochlea have shown that gentamicin-induced
hair cell death can be reduced upon the addition of S1P
or increased by the presence of ceramide in the culture
media, suggesting that hair cells could respond to these
sphingolipids (Nishimura et al., 2010). Moreover, a recent
work provides some details on the molecular mechanism that
is responsible for the protective effect of S1P on hair cells.
Indeed, S1P1–3 were found to be expressed in rat cochlea,
both in spiral ganglion and OC, by non quantitative RT-
PCR analysis and more interestingly an S1P2 antagonist was
capable to augment gentamicin-induced hair cell loss, pointing
at a role of this receptor in inner ear cell survival (Nakayama
et al., 2014). Therefore it is not clear if the effect of ceramide
and S1P may also occur indirectly by a secreted signal
released from supporting cells, where for example S1P2 has
been observed (Herr et al., 2007). Nonetheless, the insights
could have an important implication for the use of these
metabolites as otoprotective agents. In addition, it remains
to be addressed if S1P and ceramide content change after
ototoxic damage in vivo in the cochlea, this could shed new
light into the role of these sphingolipids during hair cell
degeneration.
Single S1pr2 and double S1pr2/S1pr3 KO have been shown
to be profoundly deaf by the third postnatal week (MacLennan
et al., 2006; Herr et al., 2007; Kono et al., 2007). Histological
examination of the mutants at 6 weeks after birth shows a normal
cochlear structure devoid of hair cells and auditory neurons.
Kono et al. suggested that the loss of auditory function was
caused by defects in the SV, a highly vascularized structure
that maintains the EP. Indeed, well before the loss of hair
cell and neurons, at postnatal week 2, a thickened SV with
aberrant capillaries morphology and defects in the marginal cell
boundaries could be observed (Kono et al., 2007). However, K+
concentration and the EP were not measured in these mutant
mice. Thus, the loss of hair cells could not be completely
attributed to an altered EP. Recently, the S1P specific transporter
SPNS2 was found to be involved in audition, as mutant mice
showed a gradual and profound hearing loss starting from
the second postnatal week (Chen et al., 2014). Similarly to
the S1pr2 KO mice, Spns2 mutants showed defects in the SV
characterized by thicker capillaries with increased branching,
as well as abnormal marginal cell borders. These defects and
a decrease in the EP were the earliest abnormalities observed
in the Spns2 KO (P14). Thus, it was concluded that SPNS2
is necessary to maintain the function of the SV and the EP,
while the loss of hair cells and the downregulation of KCNQ1,
KCNJ10, GJB2 and GJB6, known to maintain the EP, was
secondary. This work is in agreement with the results obtained
in the S1pr2 KO mice (Kono et al., 2007), and suggests an
involvement of the S1P-SPNS2-S1P2 axis in the maintenance
of the structure of the SV. However, how the S1P signaling
maintains the EP is not clear, indeed, in the Spns2 KO mice no
permeability between perylimph and endolymph compartments,
neither leakage from the capillaries of the SV was observed in
the mutants (Chen et al., 2014). In this regard, S1P has shown
to increase the excitability of cardiac fibroblast by activating
the K+ channel KIR6.1 in a S1P3-dependent manner (Benamer
et al., 2011) or increase the firing rate of rat hippocampal
neurons (Norman et al., 2010), suggesting that this pathway
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TABLE 1 | Knockout models for genes involved in sphingolipid metabolism and signaling have been found to present inner ear defects.




Edg5, H218, LPb2, S1P2,
Gpcr13
Mouse At 1 month of age there was a profound hearing loss together with a
decreased number of hair cells, at 4 months spiral ganglion neurons
were completely absent as well. At P14 a thickened stria vascularis with
disorganized marginal and basal cells was observed as well as thick
vessels with excessive branches.
Kono et al. (2007)
Approximately 40% of 2 months old KO mice displayed a vestibular
phenotype, while invariably all mice were deaf from P22, the onset of
degeneration of the Organ of Corti, characterized by an abnormally thin
stria vascularis, loss of hair cells and a striated tectorial membrane.




Mouse In combination with S1pr2 knockout (KO), there was a progressive loss
of hair cells and spiral ganglion neurons starting at 1 month of age.
Herr et al. (2007)
Alternative names:
Edg3, Lpb3, S1p3,
AI132464 The double KO S1pr2 and S1pr3 showed in addition to hearing loss, a
vestibular phenotype not present in the single KO S1pr2.





Zebrafish Downregulation or overexpression of s1pr2 gene reduced the size of
the posterior otolith, altered its morphology at 48 h postfertilization and
later, at 72 h disturbed the formation of the semi-circular canals. In
addition, there was a decrease in the number of lateral line neuromast
or these were shrunken with less hair cells and a higher proportion
of apoptotic cells at 6 days postfertilization. Conversely s1pr2 mRNA
injection increased the number of posterior neuromast and the number
of hair cell within the neuromast.
Hu et al. (2013)
Spinster homolog 2
(Spns2)
Mouse Progressive hearing loss started at P14 and was almost complete by
the third postnatal week, robust drop in the endocochlear potential was
observed during this window followed by hair cell loss at 1 month of
age. Other defects included an excessive branching of capillary net and
reduced number of marginal cells in the stria vascularis, no vestibular
problems were observed.
Chen et al. (2014)
Sphingomyelin synthase 1
(Sgms1) Alternative names:
Mob, Sms1, Sor1, C80702,
Tmem23, AI841905,
9530058O11Rik
Mouse Auditory brain response analysis from 1 month of age onwards showed
that the low and middle frequency hearing regions were the most
affected. In line with the phenotype, there was a drop of approximately
20 mV in the endocochlear potential together with a thin and shortened
stria vascularis in the mutants. Within the stria vascularis, the marginal
cells look disorganized.




Alternative names: 3S-T, Siat9,
GM3 synthase
Mouse Hearing loss evident at P14, selective degeneration of the organ of Corti
while the rest of the cochlear structures were morphologically normal as
well as the endocochlear potential.
Yoshikawa et al. (2009)
can regulate electrophysiological properties in diverse cell types.
Another open question that deserves further investigation is
the possible involvement of other S1P transporters in the inner
ear. For instance in the S1pr2 KO mice, a vestibular phenotype
was observed while in the Spns2 mutant only hearing function
was disrupted. In this regard, it is unknown if in the vestibular
system other S1P transporters may substitute the function of
SPNS2. Only the MRP1 transporter has been found in the
auditory and vestibular system and although it is known to
transport S1P in other systems (Mitra et al., 2006), no vestibular
phenotypes has been reported in the KO mice (Zhang et al.,
2000). Other non-specific S1P transporters have been found
in the mice sensory epithelia such as ABCG2 (Savary et al.,
2007), but it is not known if it has role in regulating the
extracellular levels of S1P. In fact, it is also unknown if the
local release of S1P is necessary to maintain the EP as S1P
has not been measured in the cochlea of WT or in Spns2
KOmice.
In addition, a direct involvement of the S1P signaling in
the maintenance of hair cells separate from the EP cannot be
ruled out until cell type specific mutants become available. In
this regard there are some indications that S1P signaling may
have a direct role in sensory cells, evidenced for example by
the localized expression of SPNS2 in outer hair cells (Chen
et al., 2014), S1P2 expression in supporting cells and S1P3 in
that area of SGN (Herr et al., 2007). Even more, the zebrafish
ortholog of mammal S1pr2, miles-apart (mil) has been expressed
during developmental stages at positions where the neuromast
develop. In addition mil morphants have a reduced number
of neuromasts in the lateral line while the mRNA transfected
embryos have an excess of neuromasts. Equally, morphants
and mRNA transfected animals presented patterning defects
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in the otic vesicles (Hu et al., 2013). In summary, at least in
the zebrafish S1P2 is involved in the formation of the otic
vesicle and hair cells. If it has a similar role in the mouse
has not been studied yet although the gross morphology of
the cochlea and the hair cells is normal at birth in the S1pr2
KOmice.
Altogether these works indicate that sphingolipids are
essential for normal hearing function, but their molecular targets
are still to be discovered either in the sensory epithelium itself,
the spiral ganglion and importantly, in the SV, that shows
some of the earliest defects in the KO models. The results
described before are summarized and presented in Table 1.
Another important aspect to be explored in the future will be the
relationship between different categories of sphingolipids, using
cell lines derived from these animal models. Those studies will
help us to pinpoint if there is a common mechanism involving
hearing loss in the models described before. Such a task will be
accomplished further with the help of cell lines with selective
deletion of enzymes and receptors involved in S1P signaling
axis, and possibly by using iPS-derived cells to uncover the role
of S1P signaling during the differentiation of inner ear sensory
cells.
Conclusions and Remaining Questions
Overall, the here reported experimental findings highlight
the crucial role of S1P signaling axis in inner ear biology.
However there are several remaining questions that deserve
further investigation. The different animal models discussed
here support that S1P signaling is necessary during inner ear
maturation and hearing at postnatal age in mice. Nonetheless,
to our knowledge only one study in the zebrafish has assessed
the involvement of this pathway during development (Hu et al.,
2013). Thus, it remains to be seen if deletion of S1P receptors or
S1P-metabolizing enzymes in mice affect gene expression in the
inner ear at early developmental stages.
Importantly, it is still necessary to investigate in more detail
the molecular mechanism by which S1P axis is regulating inner
ear function in postnatal age, such as the modulation of growth
factor receptors, the expression of K+ channels, critical for the
EP, as well as the activation of prosurvival pathway in hair cells
and sensory neurons. This is important and consistent with
the variety of biological effects elicited by S1P in diverse cell
types.
Future studies will confidently clarify the molecular
mechanisms that regulate S1P metabolism and S1P receptor
expression in the various aspects of inner ear sensory cell biology
and hopefully they will disclose the therapeutic potential of S1P
signaling pathway in hearing loss.
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